Contact
Please use this form to send email to PR contact of this press release:
MacroGenics Earns $60 Million Milestone with U.S. FDA Approval of Teplizumab
TO:
Please use this form to send email to PR contact of this press release:
MacroGenics Earns $60 Million Milestone with U.S. FDA Approval of Teplizumab
TO: